Pakistan gives green light for China's Sinopharm COVID-19 vaccine
Xinhua
| Published: 3:28 PM Jan 19 2021
World
The Drug Regulatory Authority of Pakistan (DRAP) has approved a vaccine by China's Sinopharm for emergency use due to the rapidly increasing cases of COVID-19 in the country.
A vaccine manufactured by AstraZeneca was also given authorization earlier.
The cabinet committee approved the Sinopharm vaccine, considering its safety and affordability, says Chaudhry Fawad Hussain, the country's minister for science and technology.
Pakistan reported 1,920 new coronavirus infections and 46 deaths on Monday, bringing the total number of cases to 521,211 with 10,997 deaths.
Xinhua
| Published: 3:28 PM Jan 19 2021
More News
World
2:51 PM Feb 28 2021
Myanmar's U.N. ambassador vows to fight after junta fired him
World
8:11 AM Feb 26 2021
US carries out air strikes in Syria targeting Iranian backed militias
World
5:37 PM Feb 25 2021
Johnson & Johnson's one-dose vaccine closes in on U.S. approval
World
4:27 PM Feb 25 2021
China's Xi trumpets 'victory' in campaign to end rural poverty
World
11:00 AM Feb 23 2021
Facebook to restore pages in Australia after changes to landmark legislation
Local
8:28 AM Feb 23 2021
Modi allows Imran Khan to use airspace for visit to SL
World
2:28 PM Feb 22 2021
Maldivian parliament accepts emergency motion on harbour development project with India
World
10:20 PM Feb 21 2021
Russia detects first human infection of bird flu
World
5:18 PM Feb 21 2021
India's Serum Institute says prioritising domestic vaccine needs, asks for patience
World
12:05 PM Feb 21 2021